Treatment-refractory Tourette syndrome;Sindrome di Tourette e refrattarietà ai trattamenti

Italian Journal of Psychopathology

Volumn 17, Issue 2, 2011, Pages 225-233

  Porta, M ^a   Menghetti, C ^a   Sassi, M ^a   Brambilla, A ^a   Defendi, S ^a   Servello, D ^a   Selvini, C ^d   Eddy, C ^b   Rickards, H ^b   Cavanna, Andrea Eugenio ^b,c  

^a IRCCS ISTITUTO ORTOPEDICO GALEAZZI   (Italy)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF INSUBRIA   (Italy)

Author keywords

Deep brain stimulation; Refractoriness; Tics; Tourette syndrome; Treatment

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; BENZODIAZEPINE; BOTULINUM ANTISERUM; CLOMIPRAMINE; DOPAMINE RECEPTOR BLOCKING AGENT; FLUVOXAMINE; PERGOLIDE; TETRABENAZINE;

BRAIN DEPTH STIMULATION; EUROPE; GILLES DE LA TOURETTE SYNDROME; HUMAN; MEDICAL DECISION MAKING; MEDICAL LITERATURE; OBSESSIVE COMPULSIVE DISORDER; PATIENT REFERRAL; QUALITY OF LIFE; RECURRENT DISEASE; REVIEW; SYSTEMATIC REVIEW; TREATMENT RESPONSE;

EID: 79960357703     PISSN: 15921107     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (53)

1. Clementi F, Fumagalli G. Farmacologia generale e molecolare. Terza edizione. Torino: Utet 2004.
2. th edn - text revision (DSM-IV-TR). Washington, DC: APA 2000.
3. th revision. Geneva: WHO 1992.
4. nd edn. Oxford: Oxford University Press 1998.
5. Robertson MM, Cavanna AE. Tourette Syndrome. In: HowMn P, Charman T, Ghaziuddin M, editors. Handbook of developmental disorders: science and practice. London: Sage 2010, in press.
6. rd edn. Oxford: Oxford University Press 2008.
7. Kimber TE. An update on Tourette syndrome. Curr Neurol Neurosci Rep 2010;10:286-91.
8. Cavanna AE, Shah S. Update on Tourette syndrome. Psychiatric Times 2010;27:32-4.
9. Jankovic J. Tourette's syndrome. N Engl J Med 2001;345:1184-92.
10. Cavanna AE, Schrag A, Morley D, et al. The Gilles de la Tourette Syndrome-Quality of Life scale (GTS-QOL): development and validation. Neurology 2008;71:1410-6.
11. Eddy CM, Rizzo R, Gulisano M, et al. Quality of life in young people with Tourette syndrome: a controlled study. J Neurol 2010 Sep 23 [Epub ahead of print].
12. Eddy CM, Cavanna AE, Gulisano M, et al. Clinical correlates of quality of life in Tourette syndrome. Mov Disord 2010 Nov 10 [Epub ahead of print].
13. rd edn. New York: Oxford University Press 2009, pp. 241-66.
14. Cavanna AE, Cavanna S, Bertero L, et al. Multiple self injurious behaviours in Gilles de la Tourette syndrome. J Pediatr Neurol 2009;7:293-6.
15. Cavanna AE, Mula M, Critchley HD, et al. The psychopathological spectrum of Gilles de la Tourette syndrome. Giorn Ital Psicopat 2006;12:433-43.
16. Cavanna AE, Servo S, Monaco F, et al. More than tics: the behavioral spectrum of Gilles de la Tourette syndrome. J Neuropsychiatry Clin Neurosci 2009;21:13-23.
17. Cavanna AE, Stecco A, Rickards H, et al. Corpus callosum abnormalities in Tourette syndrome: a MRI-DTI study of monozygotic twins. J Neurol Neurosurg Psychiatry 2010;81:533-5.
18. Draganski B, Martino D, Cavanna AE, et al. Multispectral brain morphometry in Tourette syndrome persisting into adulthood. Brain 2010;133:3661-75.
19. Stern E, Silbersweig DA, Chee KY, et al. Functional neuroanatomy of tics in Tourette syndrome. Arch Gen Psychiatry 2000;57:741-8.
20. Robertson MM, Cavanna AE. The Gilles de la Tourette syndrome: a principal component factor analytic study of a large pedigree. Psychiatr Genet 2007;17:143-52.
21. Swedo SE, Leonard HL, Garvey M, et al. Identification of children with pediatric autoimmune neuropsychiatrie disorders associated with streptococcal infections by a marker associated with rheumatic fever. Am J Psychiatry 1997;154:110-2.
22. Cavanna AE, Martino D, Orth M, et al. Neuropsychiatric-developmental model for the expression of tics, pervasive developmental disorder, and schizophreniform symptomatology associated with PANDAS. World J Biol Psychiatry 2009;10:1037-8.
23. Martino D, Draganski B, Cavanna AE, et al. Anti-basal ganglia antibodies and Tourette's syndrome: a voxel based morphometry and diffusion tensor imaging study in an adult population. J Neurol Neurosurg Psychiatry 2008;79:820-2.
24. Porta M, Brambilla A, Cavanna AE, et al. Thalamic deep brain stimulation for treatment-refractory Tourette Syndrome: two-year outcome. Neurology 2009;73:1375-80.
25. Porta M, Sassi M, Ali F, et al. Neurosurgical treatment for Gilles da la Tourette syndrome: the Italian perspective. J Psychosom Res 2009;67:585-90.
26. Scahill L, Erenberg G, Berlin CM, et al. Contemporary assessment and pharmacotherapy of Tourette syndrome. NeuroRX 2006;3:192-206.
27. Visser-Vandewalle V, Van der Linden C, Temel Y, et al. Chronic High-Frequency Stimulation of the Thalamus for Gilles de la Tourette Syndrome: Report of Three Cases. Acta Neurochir 2002;144:1072.
28. Dehning S, Mehrkens JH, Muller N, et al. Therapy - refractory Tourette syndrome: beneficial outcome with globus pallidus internus deep brain stimulation. Mov Disord 2008;23:1300-2.
29. Ben Djebara M, Worbe Y, et al. Aripiprazole: a treatment for severe coprolalia in "refractory" Cilles de la Tourette syndrome. Mov Disord 15;23:438-40.
30. Davies L, Stern JS, Agrawal N, et al. A case series of patients with Tourette's syndrome in the United Kingdom treated with aripiprazole. Hum Psychopharmacol 2006;21:447-53.
31. Servello D, Porta M, Sassi M, et al. Deep Brain Stimulation in 18 patients with severe Cilles de la Tourette syndrome refractory to treatment: the surgery and stimulation. J Neurol Neurosurg Psychiatry 2008;79:136-42.
32. Salloway S, Stewart CF, Israeli L, et al. Botulinum toxin for refactory vocal tics. Mov Disord 1996;11:746-8.
33. Kuhn J, Lenartz D, Mai JK, et al. Deep brain stimulation of the nucleus accumbens and the internal capsule in therapeutically refractory Tourette-syndrome. J Neurol 2007;254:963-5.
34. Sun B, Krahl SE, Zhan S, et al. Improved capsulotomy for refractory Tourette's syndrome. Stereotact Funct Neurosurg 2005;83:55-6.
35. Rickards H, Wood C, Cavanna AE. Hassler and Dieckmann's seminal paper on stereotaxic thalamotomy for Cilles de la Tourette syndrome: translation and critical reappraisal. Mov Disord 2008;23:1966-72.
36. Hassler R, Dieckmann G. Stereotactic treatment of tics and inarticulate Crises of coprolalia considered as motor obsessional phoenomena in Gilles de la Tourette's disease. Rev Neurol (Paris) 1970;123:89-100.
37. Halpern C, Hurtig H, Jaggi J, et al. Deep brain stimulation in neurologic disorders. Parkinsonism Relat Disord 2007;13:1-16.
38. Machado A, Rezai AR, Kopell BH, et al. Deep brain stimulation for Parkinson's disease: surgical technique and perioperative management. Mov Disord 2006;21(Suppl 14):S247-58.
39. Benabid AL, Benazzouz A, Hoffmann D, et al. Long-term electrical inhibition of deep brain targets in movement disorders. Mov Disord 1998;13(Suppl 3):S119-25.
40. Vandewalle V, Van der Linden C, Groenewegen HJ, et al. Stereotactic treatment of Gilles de la Tourette syndrome by high frequency stimulation of thalamus. Lancet 1999;353:724.
41. Sturm V, Lenartz D, Koulousakis A, et al. The nucleus accumbens: a target for deep brain stimulation in obsessive-compulsive- and anxiety-disorders. J Chem Neuroanat 2003;26:293-9.
42. Mink JW, Walkup J, Frey KA, et al. Patient selection and assessment recommendations for deep brain stimulation in Tourette syndrome. Mov Disord 2006;21:1831-8.
43. Leckman JF. Tourette's syndrome. Lancet 2002;360:1577-86.
44. Maciunas RJ, Maddux BN, Riley DE, et al. Prospective randomised double-blind trial of bilateral deep brain stimulation in adults with Tourette syndrome. J Neurosurgery 2007;107:1004-14.
45. Ackermans L, Temel Y, Visser-Vandewalle V. Deep brain stimulation in Tourette's syndrome. Neurotherapeutics 2008;5:339-44.
46. Welter ML, Mallet L, Houeto JL, et al. Internal pallidal and thalamic stimulation in patients with Tourette syndrome. Arch Neurol 2008;65:952-7.
47. Flaherty AW, Williams ZM, Amirnovin R, et al. Deep brain stimulation of the anterior internal capsule for the treatment of Tourette syndrome: technical case report. Neurosurgery 2005;57:E403.
48. Shields DC, Cheng ML, Flaherty AW, et al. Microelectrode-guided deep brain stimulation for Tourette syndrome: within-subject comparison of different stimulation sites. Stereotact Funct Neurosurg 2008;86:87-91.
49. Bajwa RJ, de Lotbiniere AJ, King RA, et al. Deep brain stimulation in Tourette syndrome. Mov Disord 2007;22:1346-50.
50. Shahed J, Poysky J, Kenney C, et al. GPi deep brain stimulation for Tourette syndrome improves tics and psychiatric comorbidities. Neurology 2007;68:159-60.
51. Diederich NJ, Kalteis K, Stamenovic M, et al. Efficient internal palladial stimulation in Gilles de la Tourette syndrome: A case report. Mov Disord 2005;20:1496-520.
52. Houeto JL, Karachi C, Mallet L, et al. Tourette's syndrome and deep brain stimulation. J Neurol Neurosurg Psychiatry 2005;76:992-5.
53. van der Linden C, Colle H, Vandewalle V, et al. Successful treatment of tics with bilateral internal pallidum stimulation in a 27-year-old male patient with Gilles de la Tourette syndrome. Mov Disord 2002;17:S341.